Clinical Sample Database and Proteomics

$243,394P01FY2013CANIH

University Of Michigan At Ann Arbor, Ann Arbor MI

Investigators

Linked publications & trials

Paper 39222793 Paper 38968143 Paper 38640197 Paper 38640195 Paper 38548227 Paper 38324721 Paper 38320730 Paper 37142257 Paper 36350750 Paper 36095841 Paper 35703182 Paper 35643350 Paper 35443021 Paper 34669521 Paper 34474163 Paper 34471240 Paper 33201499 Paper 32582668 Paper 32020045 Paper 31779977 Paper 31738834 Paper 30504314 Paper 30482771 Paper 30399420 Paper 30201970 Paper 30176942 Paper 30106382 Paper 30087106 Paper 30057862 Paper 29545329 Paper 28951581 Paper 28581444 Paper 28484267 Paper 28194439 Paper 28017733 Paper 27625357 Paper 27416114 Paper 26873960 Paper 26687425 Paper 26551636 Paper 26386318 Paper 26359186 Paper 25972478 Paper 25729761 Paper 25687798 Paper 25455279 Paper 25125579 Paper 24527786 Paper 24492144 Paper 24295572 Paper 24046012 Paper 23924003 Paper 23892043 Paper 23760615 Paper 23290438 Paper 23205489 Paper 23200544 Paper 23165480 Paper 23149907 Paper 23065502 Paper 22955330 Paper 22889218 Paper 22469883 Paper 22286196 Paper 22226094 Paper 22155140 Paper 21979939 Paper 21384095 Paper 21270339 Paper 21195297 Paper 21091111 Paper 20371463 Paper 20302964 Paper 20113888 Paper 19812490 Paper 19282026 Paper 19147075 Paper 19041607 Paper 18832652 Paper 18721764 Paper 18541194 Paper 18502834 Paper 18460880 Paper 18411417 Paper 18042798 Paper 17950916 Paper 17786233 Paper 17365261 Paper 16478883 Paper 16440318 Paper 16289694 Paper 16125638 Paper 15753842 Paper 15625121 Paper 15446306 Paper 15258462 Paper 15205666 Paper 15205258 Paper 15187116 Paper 15148490

Abstract

PROJECT SUMIVIARY (See instructions): Core C will provide support for research sample collection for BMT patients and ensure proper and consistent quality control regarding the collection, processing, archiving and distribution of samples. Core C will also ensure quality control of the clinical status and endpoints of individuals whose samples are collected and analyzed. In addition, Core C will continue to support exploratory proteomic profiling of clinical research samples from allogeneic BMT patients. During this last cycle. Core C has been instrumental in the development and validation of a four biomarker panel of GVHD. The services provided by Core C will include the following: 1. To collect, process, store, and distribute patient derived research samples 2. To collect data for, quality control, and maintain the integrated comprehensive patient database 3. To provide cutting edge proteomic analysis technology

View original record on NIH RePORTER →